The impact of outpatient versus inpatient management on health-related quality of life outcomes for patients with malignant pleural effusion: the OPTIMUM randomised clinical trial
Conclusions
While HRQoL significantly improved in both groups, there were no differences in patient-reported global health status at 30 days. The outpatient pathway using an IPC was not superior to inpatient treatment with a chest drain.
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Sivakumar, P., Fitzgerald, D. B., Ip, H., Rao, D., West, A., Noorzad, F., Wallace, D., Haris, M., Prudon, B., Hettiarachchi, G., Jayaram, D., Goldring, J., Maskell, N., Holme, J., Sharma, N., Ismail, I., Kadwani, O., Simpson, S., Read, C. A., Sun, X., Dou Tags: Lung cancer Original Articles: Pleural disease Source Type: research
More News: Cancer | Cancer & Oncology | Clinical Trials | Lung Cancer | Pain | Pain Management | Respiratory Medicine